Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Coexisting dysfibrinogenemia (gammaR275C) and factor V Leiden deficiency associated with thromboembolic disease (fibrinogen Cedar Rapids).

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis - 1 Apr 2000

Siebenlist K R, Mosesson M W, Meh D A, DiOrio J P, Albrecht R M, Olson J D

Abstract excerpt

Fibrinogen Cedar Rapids is a heterozygous dysfibrinogenemia (gammaR275C) that was associated with thromboembolism during and following pregnancy in three second-generation family members who also were heterozygotic for factor V Leiden (V R506Q). Like other dysfibrinogenemias with substitutions at position 275 of the gamma-chain, fibrinogen Cedar Rapids is characterized by defective end-to-end intermolecular...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Factor V
Share to Fibrinogen

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Heterozygote

Share to Mutation

Share to Pedigree

Share to Pregnancy

Share to Pregnancy Complications, Cardiovascular

Share to Thromboembolism

Source

Identifiers

PMID: 10870810

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Coexisting dysfibrinogenemia (gammaR275C) and factor V Leiden deficiency associated with thromboembolic disease (fibrinogen Cedar Rapids).PMID 10870810Read ↗

Congenital fibrinogen disorders: an update.Semantic proximity Read ↗

Congenital fibrinogen disorders.Semantic proximity Read ↗

Fibrinogen bellingham: a gamma-chain R275C substitution and a beta-promoter polymorphism in a thrombotic member of an asymptomatic family.Semantic proximity Read ↗

Rare inherited disorders of fibrinogen.Semantic proximity Read ↗

Functional and structural consequences of fibrinogen γ-chain variants associated with thrombotic phenotype in congenital fibrinogen disorders.Semantic proximity Read ↗

Heterogeneity of Genotype–Phenotype in Congenital Hypofibrinogenemia—A Review of Case Reports Associated with Bleeding and ThrombosisSemantic proximity Read ↗

Genetics, diagnosis and clinical features of congenital hypodysfibrinogenemia: a systematic literature review and report of a novel mutation.Semantic proximity Read ↗

Genetic Variants in the FGB and FGG Genes Mapping in the Beta and Gamma Nodules of the Fibrinogen Molecule in Congenital Quantitative Fibrinogen Disorders Associated with a Thrombotic Phenotype.Semantic proximity Read ↗

Diagnosis, clinical features and molecular assessment of the dysfibrinogenaemias.Semantic proximity Read ↗

An exploratory plasma-based functional assay for phenotypic characterization of fibrinolysis in dysfibrinogenemia.Semantic proximity Read ↗

Congenital Hypodysfibrinogenemia due to γ326Cys→Tyr Mutation: Third Ever-Described Case Associated with Recurrent Venous Thrombosis and COVID Vaccine.Semantic proximity Read ↗

Dysfibrinogenemia: from molecular anomalies to clinical manifestations and management.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.